<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The development of collateral vessels, which is important to prevent ischemic tissues from cell <z:hpo ids='HP_0011420'>death</z:hpo>, is impaired in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The process is regulated by many positive and negative factors </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of the study is to test the hypothesis that <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with <z:mp ids='MP_0002055'>diabetes</z:mp> have <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> deficiency and the possible mechanism is <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> attenuates neovascularization by downregulating proliferative properties of vascular endothelial growth factor (VEGF) and upregulating negative properties of angiostatin </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:mp ids='MP_0002055'>Diabetes</z:mp> groups [Goto-Kakizaki (GK)] and respective controls (Wistar rats) underwent 1.5h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and then reperfused for 24h and 7d </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemistry was used to describe the change of vessel density </plain></SENT>
<SENT sid="5" pm="."><plain>The expression levels of VEGF and angiostatin were estimated by western blot </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Compared with the controls, the <z:mp ids='MP_0002055'>diabetes</z:mp> groups had lower vessel density, more expression of angiostatin, and lower level of VEGF </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results showed <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> was deficient in <z:mp ids='MP_0002055'>diabetes</z:mp> groups after ischemic reperfusion (I/R) injury </plain></SENT>
<SENT sid="8" pm="."><plain>And the possible mechanism is <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> attenuates neovascularization by downregulating proliferative properties of VEGF and upregulating of negative properties of angiostatin </plain></SENT>
</text></document>